SCIENCE MADE SIMPLE
Stay Updated! Subscribe to The Primer
Share
When a new drug is in the pipeline, the FDA can slap on a few “designations” to speed things along. Sounds bureaucratic? Maybe. But for biotech companies, these designations are like golden tickets—and for patients, they can mean faster access to lifesaving meds. In...
Transgenic mice—genetically modified mice with added or deleted genes—are the unsung heroes of drug development. These tiny lab warriors help scientists understand diseases, test drugs, and even produce monoclonal antibodies used as medicines. If there’s a scientific...
With over 7,000 rare diseases affecting more than 30 million Americans, these conditions—many of them genetic—often lack effective treatments.
Discovering drugs isn’t a one-size-fits-all process. It’s a mix of strategies, blending creativity, science, technology, and even luck. Click to learn more.
The market for PARP inhibitors, a cornerstone in targeted cancer treatment, is projected to more than triple from $3 billion in 2022 to an estimated $10.3 billion by 2031.
Discover the latest treatments for heart disease. From generic competition to innovative solutions, find out how the industry is evolving.
Biological drugs — composed of proteins produced by living cells — have become some of the safest, most effective therapeutics in the pharmaceutical industry.
Understand the process of drug metabolism and how our bodies respond to medication at a cellular level.
Learn about the global regulatory process when bringing new medications to the market, from the FDA to other governing bodies.
Epigenetics refers to the study of changes in gene activity that occur without altering the underlying DNA sequence. Epigenetic changes…
Biotech Primer is your go-to source for interactive training across the biotechnology, pharmaceutical, molecular diagnostics, and medical device sectors. Explore a range of in-depth biotech courses designed to deepen your understanding of key principles and applications in the field.